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Background: To investigate whether schizophrenia patients with both suicide attempts and non-suicidal self-harm
have earlier age of onset of psychotic and depressive symptoms and higher levels of clinical symptoms compared
to patients with only suicide attempts or without suicide attempt.
Methods: Using a cross-sectional design, 251 patients (18–61 years old, 58% men) with schizophrenia treated at
hospitals in Oslo and Innlandet Hospital Trust, Norway, were assessed with a comprehensive clinical research
protocol and divided into three groups based on their history of suicide attempts and non-suicidal self-harm.
Results: Suicide attempts were present in 88 patients (35%); 52 had suicide attempts only (29%) and 36 had both
suicide attempts and non-suicidal self-harm (14%). When compared with nonattempters and those with suicide
attempts without non-suicidal self-harm, patients with both suicide attempts and non-suicidal self-harm were more
frequently women, younger at the onset of psychotic symptoms, had longer duration of untreated psychosis, and
had higher levels of current impulsivity/aggression and depression. Patients with both suicide attempts and
non-suicidal self-harm were more likely to repeat suicide attempts than patients with suicide attempts only.
Conclusions: Patients with both suicide attempts and non-suicidal self-harm had different illness history and
clinical characteristics compared to patients with only suicide attempts or patients without suicidal behavior. Our
study suggests that patients with both suicide attempts and non-suicidal self-harm represent a distinct subgroup
among patients with schizophrenia and suicidal behavior with their early onset of psychotic symptoms, high rate of
repeated suicidal behavior and significant treatment delay.
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Suicide is a significant problem in schizophrenia and sui-
cide attempts (SA) are common [1-3]. Some risk factors
for SA are shared with other populations, including de-
pression, hopelessness, substance misuse and suicidal
ideation [4]. Other risk factors for SA are more specific
to this patient group and include more relapses, a long
duration of untreated psychosis (DUP), hallucinations,* Correspondence: erlend.mork@medisin.uio.no
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reproduction in any medium, provided the orand an earlier age of onset, although for the latter the
association has been inconsistent across studies [4-8].
Furthermore, distressing psychotic symptoms might trig-
ger SA, especially among those already at risk for sui-
cidal behavior [9,10]. Suicidal behavior has been studied
extensively in schizophrenia, but we still lack knowledge
about the pathways that may serve as signs of persons at
particular risk within this high risk group.
In particular, we have little knowledge about the im-
pact of non-suicidal self-harm (NSSH) on suicidal be-
havior in this group. The limited research has focused
on extreme self-injury such as self-enucleation, which is
extremely rare [11]. More common forms of NSSH, such
as repeated cutting, burning and self-hitting are frequentlyd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pleted suicide, but have not received notable attention in
studies of patients with schizophrenia [12]. Importantly,
NSSH has been found to be an independent risk factor for
both attempted [13] and completed suicide [14] in other
clinical populations. Both self-reports, laboratory studies
and clinical observations indicate that regulation of nega-
tive affect is an important mechanism underlying NSSH
[15]. Studies from non-psychotic clinical samples also indi-
cate that individuals with a history of both SA and NSSH
display more severe symptoms than individuals with SA
only [16-18]. Stanley and colleagues [17] found that pa-
tients with cluster B personality disorders who had a his-
tory of both SA and NSSH tended to be more depressed,
have more persistent suicidal ideation, and more symp-
toms of affective instability and impulsivity than individuals
with SA only.
Dividing patients into risk groups according to behav-
ior is one way to increase our understanding [19]. Based
on this, NSSH may be an important pathway to suicidal
behavior also in schizophrenia patients. One explanation
for the inconsistent association between age of onset
and suicide attempts in schizophrenia may be that onset
of clinical symptoms (psychotic and depressive) in adoles-
cence will increase the risk of suicide attempts only in the
subgroup of patients that are already more prone to use
self-harm to regulate emotions. In a previous study we
have shown that the presence of self-harm (encompassing
both SA and NSSH) is associated with younger age of on-
set of schizophrenia [20]. Self-harm was also associated
with depression, current suicidal ideation in both genders,
and impulsive aggression in women. This study protocol
did not initially differentiate between SA and NSSH. In the
current study, however, we have used an expanded proto-
col assessing life-time SA and NSSH separately. Based on
the hypothesis that patients with both SA and NSSH repre-
sent a separate subgroup characterized by earlier onset and
more affective and impulsive symptoms, the aim of the
present study was to investigate: 1) Whether patients with
SA + NSSH have earlier onsets of clinical symptoms
(psychotic and/or depressive) and 2) Whether patients with
SA + NSSH report more impulsive aggression, suicidal
ideation and depressive symptoms than SA patients with-
out NSSH or patients without SA.
Methods
The study was part of the Thematically Organized Psych-
osis (TOP) Study including patients with psychotic disor-
ders from in- and outpatient clinics at the major hospitals
in Oslo and Innlandet Hospital Trust, Norway. Recruit-
ment of participants, inclusion criteria and clinical as-
sessments are described briefly below. More detailed
information can be found elsewhere [6,20]. The study
was approved by The Regional Committee for Medicaland Health Research Ethics South East, Norway and by the
Norwegian Data Protection Agency.
Participants
The current study sample consisted of 251 patients, 139
outpatients (55%) and 112 inpatients, with a DSM-IV
narrow schizophrenia spectrum disorder (DSM IV 295.xx)
consecutively included between April 2007 and November
2010. The age range of the participants was 18–61 years,
with a mean age of 30.1 years (SD = 9.8 years). Fifty-eight
per cent of subjects were men (n = 145), the majority of
participants (82%) were of European origin and 81% were
single.
Clinical assessments
Clinical psychologists or medical doctors, with formal
training in use of the assessment protocol, interviewed
the patients when in a stable phase. The Structured Clin-
ical Interview for DSM-IV Axis I disorders (SCID-I) [21]
was used for diagnostic purposes. Mean overall kappa for
SCID diagnoses as assessed in the training course was 0.77.
Age of onset was defined as age at the first SCID-verified
psychotic episode. Clinical symptoms were assessed using
the Positive and Negative Syndrome Scale, PANSS [22]. All
interviewers participated in inter-rater reliability testing
that entailed rating of patient videos. Inter-rater reliability
was acceptable with intra-class correlation coefficients [23]
for PANSS subscales ranging from 0.71 to 0.73. The
PANSS item G14 (Disordered regulation and control of ac-
tion on inner urges/emotions) was used as a proxy for im-
pulsive aggression in the past week. Suicidal ideation last
week was measured using five items from the InterSePT
scale for suicidal thinking [24]. Duration of untreated
psychosis was measured as time from psychosis onset until
start of adequate treatment for psychotic disorder [25].
The concept self-harm (SH) [26] was subdivided into
SA, defined as ‘self-harm with the intent to die’, and
NSSH, defined as ‘self-harm without suicide intent’. NSSH
thus encompasses both non-suicidal self-injury and self-
poisoning for purposes of self-injury without suicidal
intent. Information on lifetime episodes of self-harm was
based on a semistructured interview including the follow-
ing question adopted from a previous European study of
self-harm (CASE-study): “Have you ever deliberately taken
an overdose (e.g., of pills or other medication) or tried to
harm yourself in some other way (such as cut yourself)?”
[26,27]. The response options were “no”, “yes” and if yes,
“the specific number of times” with the follow-up ques-
tion: “how many times did you try to kill yourself?” (SA)
and “How many times did you harm yourself without a
wish to die” (NSSH). The presence of any suicide intent
led to classification of the behavior as a suicide attempt,
also in the presence of seemingly contradictory additional
reasons given for the behavior (such as “I wished to get
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tion, the classification was based on an open description
of the participants’ most recent episode of self-harm,
whether they considered the behavior a suicide attempt
(yes, no, uncertain), and on answers to questions about
what they wanted to achieve with the act (“I wished
to die” (yes/no), “I wished to get help from someone”
(yes/no), “I wished to escape an unbearable emotion”
(yes/no), ”Other reasons (describe)”). The principal author
reviewed all classifications of self-harm variables and in
the few cases (n = 6) with a discrepancy, a consensus was
reached with the senior author. This defined three groups
relative to the presence of SA: 1) NoSA (patients with no
SH and NSSH only), 2) SA only (participants with history
of SA, but no NSSH) and 3) SA + NSSH (participants with
both SA and NSSH) (see Figure 1).
Statistical analyses
Group differences were analyzed using Chi-square tests
for categorical variables, one-way ANOVAs (post-hoc
Scheffé’s tests) for normally distributed continuous vari-
ables and Kruskal-Wallis test (post hoc Mann–Whitney
U test) for non-normally distributed continuous variables.
Pairwise comparisons were performed comparing the SA +
NSSH group with the SA only and with the NoSA groups,
based on the research questions. All tests were two-tailed
with α < 0.05. Two multinomial logistic regression models
were generated to answer the two research questions.
Backward stepwise procedures (p in = 0.05: p out = 0.10)










NoSA (n=163): NoSH + NSSH only
Figure 1 Grouping of patients according to life-time prevalence
of self-harm behaviors. NSSH: non-suicidal self-harm (n = 75) SA:
suicide attempt (n = 88). NoSH : no self-harm (n = 124) NoSA : no
suicide attempt (n = 163).between participants with SA + NSSH, SA only, and
NoSA history. DUP and impulsive aggression (G14) were
skewed and dichotomized at the median (DUP > 52 weeks/
G14 > 1) in the regression analysis. We also included vari-
ables that were differentially distributed over groups and
thus could confound relationships. Current age and age of
first psychotic symptoms were highly correlated and since
age of first psychotic symptoms was of primary interest,
this measure was retained in the models. We used the
PASW statistics v.18 software (SPSS Inc., Chicago, Illinois).
Results
Rates and characteristics of NSSH and SA
A total of seventy-five patients (30%) reported one or
more episodes of NSSH. The median number of NSSH
episodes was six (min = 1, max ≥ 50), 22 patients (9% of
total sample) reported 50 episodes or more. Women
were significantly more likely to report at least one
NSSH episode (43% (n = 46) vs. 20% (n = 29), χ2 = 16.00,
DF = 1, p < 0.001). When the most recent self-harm epi-
sode was NSSH (n = 54), it had little or no risk of death
(n = 52/96%), the behavior had been planned for less than
an hour in 35 cases (65%), and the most commonly used
method was cutting (n = 42/78%). Among those with SA +
NSSH, almost all patients reported cutting as method,
when the most recent episode was NSSH (n = 17/94%),
indicating that NSSH in this group primarily consists of
self-injury. One or more episodes of SA were present in 88
patients (35%), the median number of SA among these was
two (min = 1, max = 7). Significantly more women reported
history of SA (47% (n = 50) vs. 26% (n = 38), χ2 = 11.82,
DF = 1, p = 0.001). When the most recent self-harm was
SA (n = 63), the lethality was rated as moderate to high in
45 cases (77%), and the most frequent method was self-
poisoning (n = 34/54%). Patients with a lifetime history of
NSSH were significantly more likely to report SA (n = 36/
48%) than patients without NSSH (n = 52/30%, χ2 = 7.9,
DF = 1, p = 0.005). Fifty-two patients (21%) had a history of
SA only while 36 (14% of total) had a history of SA +
NSSH. The SA + NSSH group was significantly more likely
to have repeated SA (n = 28/78%) compared to the SA only
group (n = 17/33%, χ2 = 17.3, DF = 1, p < 0.001). Patients
with SA +NSSH were significantly more often female and
younger at the time of participation than patients with SA
only or NoSA (Table 1).
Illness history and medication
Patients with SA + NSSH were significantly younger at
psychosis onset than participants with SA only or NoSA
(mean difference 6.7 and 4.9 years respectively), and had
longer DUP (Table 1). SA + NSSH patients were also
significantly younger at first contact with mental health
services and more likely to have had their first mental
health contact for other reasons than psychotic disorder
Table 1 Sociodemographic variables and illness history according to history of self-harm behaviour
Overall
n = 251a
Suicide attempt n = 88 No suicide attempt Statistics (DF) Post hoce
Group 1 Group 2 Group 3
SA + NSSH SA only NoSA
n = 36 n = 52 n = 163
Age (years), mean (SD) 30.1 (9.8) 24.5 (6.3) 33.5 (10.3) 30.3 (9.9) F = 9.5 (2, 250)***b 1 < 2, 3
Women, n (%) 106 (42) 26 (72) 24 (46) 56 (34) χ2 = 17.7 (2)***c 1≠ 2, 3
Age of first psychotic symptoms, mean (SD) 22.8 (7.7) 17.6 (6.4) 24.3 ( 9.2) 23.5 (7.0) F= 10.7 (2, 249)***b 1 < 2, 3
Age of first treatment for psychiatric disorder,
mean (SD)
24.6 (9.0) 19.9 (5.6) 25.5 (9.7) 25.3 (9.2) F = 6.0 (2, 244)**b 1 < 2, 3
Age of first treatment for psychoses, mean (SD) 25.6 (7.6) 22.5 (5.0) 28.0 (8.9) 25.5 (7.5) F = 5.6 (2, 239)**b 1 < 2
First treatment for other reason than psychosis, n (%) 70 (29) 21 (58) 17 (33) 32 (20) χ2 = 21.8 (2)***c 1 > 2, 3
Duration of untreated psychoses (weeks), median
(min-max)
52 (0–2040) 181 (0–1352) 32 (1–2040) 28 (0–1248) K = 14.3 (2)**d 1 > 2, 3
Depressive episode, lifetime n (%) 129 (52) 27 (75) 42 (81) 60 (37) χ2 = 38.9 (2)***c 1 > 3
Depressive episode, first symptoms before the age
of 18, n (%)
54 (22) 20 (57) 14 (29) 20 (13) χ2 = 34.1 (2)***c 1 > 2, 3
Levels of statistical significance: ns = not significant, ** = p < 0.01, *** = p < 0.001.
SA: Suicide attempt. NSSH: Non-suicidal self-harm.
aData missing for 0–11 patients. Percentages based on valid observations, bF = One-way ANOVA test, cχ2 = Pearson chi square test, dK = Kruskal-Wallis test,
ePlanned pairwise comparisons of Group 1 (SA + NSSH) vs Group 2 (SA only) and Group 1 (SA + NSSH) vs Group 3 (NoSA) (Scheffe’s test, Pearson chi square test,
Mann–Whitney U test). Only statistically significant differences (p < .05) presented.
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cantly more likely to report to have had depressive epi-
sode(s) before the age of 18.
Current symptoms and behaviors
The SA + NSSH group had significantly higher levels of
depressive symptoms and were more likely to report
current impulsive aggression or suicidal ideation com-
pared to the SA and NoSA groups (Table 2). There were
no group differences in current levels of negative symp-
toms or total PANSS score. There was, however, a trend
towards group differences on positive symptoms (p = .08),
and significant group differences were observed on the de-
lusions and hallucinatory behavior items from the positive
symptoms score, with those with SA + NSSH scoring sig-
nificantly higher than both other groups on current hallu-
cinatory behavior. One third of the SA + NSSH patients
did not use any antipsychotic medication; a significantly
higher fraction than among NoSA patients. Regarding re-
cent SA, there were no significant differences between the
SA + NSSH and SA only groups in lethality (moderate
to high: 75% vs 77%, χ2 = 0.0, DF = 1, p = 0.854), de-
gree of hospital treatment (41% vs 49%, χ2 = 0.3, DF = 1,
p = 0.583), degree of premeditation (less than an hour: 41%
vs 43%, χ2 = 0.0, DF = 1, p = 0.887), or in method used
(self-poisoning: 59% vs 51%, χ2 = 0.3, DF = 1, p = 0.583).
Multivariate analyses
In the first model we investigated the multivariate rela-
tionships between group memberships and illness history(Aim 1, i.e. ages at onset of psychosis and depression) to-
gether with potential confounding variables of this rela-
tionship (here DUP and gender). All four variables had a
significant contribution to the model (Table 3). The SA +
NSSH group could be differentiated from the NoSA group
by a) being younger at the time of onset of their first
psychotic symptoms, b) more often having had episodes of
depression before the age of 18, c) being more often fe-
male and d) more often having a DUP of more than a year.
The SA only group could only be differentiated from the
NoSA group by more often having had episodes of depres-
sion before the age of 18. To test whether the SA + NSSH
and SA only groups were significantly different on these
measures, we performed identical multinomial analyses
with the SA + NSSH group as reference category (see
Additional file 1). These analyses confirmed that the SA +
NSSH group differed significantly from the SA only group
by a) being younger at first psychotic symptoms, b) being
more often female and c) more often having had a DUP of
more than a year. There were no significant differences
between the SA +NSSH and SA only groups in having
had episodes of depression before the age of 18.
In Model 2 we added current symptoms and behavior
to the illness history variables entered in model 1 to ad-
dress the second aim of this study. Levels of current im-
pulsive aggression and depressive symptoms contributed
to differentiate between the groups. The SA + NSSH
group had higher scores on current impulsive aggression
and depressive symptoms compared to the NoSA group.
Current depressive symptoms also differentiated the SA
Table 2 Current symptoms, medication and behavior according to history of self-harm behavior
Overall
n = 251a
Suicide attempt n = 88 No suicide attempt Statistics (DF) Post hoce
Group 1 Group 2 Group 3
SA + NSSH SA only NoSA n = 163
n = 36 n = 52
Global Assessment of Functioning, mean (SD) 41.7 (10.3) 37.4 (7.4) 41.6 (8.9) 42.6 (11.0) F = 3.9 (2, 250)**b 1 < 3
PANSS
Total, mean (SD) 67.2 (17.6) 72.0 (15.3) 66.3 (17.2) 66.3 (18.1) F = 1.6 (2, 247)ns b
Positive symptoms, mean (SD) 16.3 (5.4) 17.9 (4.1) 16.6 (5.5) 15.8 (5.5) F = 2.5 (2, 250)ns b
- PANSS P1 Delusions 3.6 (1.4) 4.1 (1.2) 3.6 (1.2) 3.4 (1.5) F = 3.7 (2, 249) *b 1 > 3
- PANSS P3 Hallucinatory behavior 3.0 (1.7) 3.9 (1.5) 2.9 (1.5) 2.8 (1.7) F = 7.0 (2, 249) **b 1 > 2, 3
Negative symptoms, mean (SD) 16.7 (6.6) 15.8 (6.4) 15.6 (5.9) 17.2 (6.8) F = 1.5 (2, 249)ns b
CDSS (current depression) suicide item excludedc,
mean (SD)
5.6 (4.7) 9.5 (5.0) 6.0 (4.6) 4.6 (4.2) F = 18.2 (2, 241) ***b 1 > 2, 3
PANSS G14 (Impulsive aggression), median (min-max) 1 (1–6) 2 (1–6) 1 (1–4) 1 (1–4) K = 24.1 (2)***c 1 > 2, 3
InterSePT 5 (Current suicidality) χ2 = 30.4 (4)***d
- No current suicidality (0), n (%) 157 (63) 13 (36) 27 (53) 117 (72)
- Low suicidality (0.1-1.0), n (%) 75 (30) 14 (39) 20 (39) 41 (25)
- Moderate to high (1.1-2.0), n (%) 18 (7) 9 (25) 4 (8) 5 (3) 1 > 2, 3f
Alcohol abuse or addiction last 6 months, n (%) 16 (7) 2 (6) 6 (12) 8 (5) χ2 = 2.9 (2)ns d
Substance abuse or addiction last 6 months, n (%) 23 (9) 4 (11) 5 (10) 14 (9) χ2 =0.2 (2)ns d
Current medication: X2 = 10.9 (4) *d
- No antipsychotic medication, n (%) 44 (18) 12 (33) 11 (21) 21 (13) 1≠ 3g
- Antipsychotic, no antidepressant, n (%) 150 (60) 16 (44) 27 (52) 107 (66)
- Antipsychotic and antidepressant, n (%) 57 (23) 8 (22) 14 (27) 35 (22)
Levels of statistical significance: ns = not significant * = p < 0.05, ** = p < 0.01, *** = p < 0.001.
aData missing for 0–9 patients, percentages based on valid observations, bF = One-way ANOVA test, cK = Kruskal-Wallis test, dχ2 = Pearson chi square test,
ePlanned pairwise comparisons of Group 1 (SA + NSSH) vs Group 2 (SA only) and Group 1 (SA + NSSH) vs Group 3 (NoSA) (Scheffe’s test, Pearson chi square test,
Mann–Whitney U test). Only statistically significant differences (p < .05) presented. f Comparing those scoring moderate to high with those with low/no current
suicidality, g Comparing those with no antipsychotic medication to those with antipsychotic medication (with/without antidepressant medication).
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aggression did not. Once current depressive symptoms
were added, length of DUP no longer contributed signifi-
cantly to the model (Model 2, Table 3). Current medica-
tion did not significantly differentiate between groups in
the multivariate analyses. The supplementary analysis with
SA + NSSH as reference category showed that the SA +
NSSH group scored significantly higher on both current
impulsive aggression and depressive symptoms compared
with the SA only group (Additional file 1).
Discussion
Our main findings are that a history of SA + NSSH in
patients with schizophrenia is associated with an earlier
onset of psychotic symptoms and a longer DUP com-
pared to patients with SA only or NoSA. SA + NSSH
were more common in females and patients with both
SA and NSSH had higher levels of current impulsive
aggression and depressive symptoms. Despite thesedifferences, the groups could not be distinguished by
characteristics of their suicide attempts, which were fre-
quently quite dangerous.
To our knowledge, this is the first study to address the
prevalence of NSSH and the clinical correlates of a his-
tory of both SA and NSSH as opposed to SA only or no
suicide attempt history in patients with schizophrenia.
We found that NSSH was relatively frequent (1/3 of the
total sample having at least one episode) as was also
SA + NSSH. In comparison, prevalence estimates of NSSH
in mixed adult general psychiatric samples vary consider-
ably with the type of data source. Chart review studies
generally report low levels (6%) [28] while self-report ques-
tionnaire studies asking specifically about a wide range of
NSSH behaviors (including scratching or skin picking) re-
port higher rates (41 - 45%) [29,30].
The NSSH behaviors reported in the current study
usually carried little death risk, were often highly repeti-
tive, and in most cases involved cutting, consistent with
Table 3 Clinical characteristics according to type of self-harm behavior. Multinomial logistic regression analysisa
Model 1: Age at onset and DUPb Model 2: Model 1 + Current symptoms
and behavior Reference category: NoSAcReference category: NoSA
SA + NSSH SA only SA + NSSH SA only
Adj. OR Adj. OR Adj. OR Adj. OR
(CI 95%) (CI 95%) (CI 95%) (CI 95%)
Age of onset and DUP
Higher age of first psychotic symptoms 0.92 (0.86 – 0.99)* 1.02 (0.98 – 1.07)ns 0.92 (0.85 – 0.99)* 1.02 (0.98 – 1.07)ns
DUP > 52 weeks (1 year) 3.10 (1.20 – 8.04)* 1.09 (0.55 – 2.17)ns - -
Women 7.41 (2.73 – 20.12)*** 1.53 (0.77 – 3.03)ns 4.63 (1.69 – 12.64)** 1.47 (0.73 – 2.99)ns
Depressive episode, first symptoms before the age of 18 4.82 (1.88 – 12.35)** 3.01 (1.31 – 6.95)* 3.36 (1.20 – 9.40)* 2.62 (1.08 – 6.32)*
Current symptoms and behavior
PANSS G14 (Impulsive aggression) > 1 5.30 (2.00 – 14.04)** 0.93 (0.42 – 2.06)ns
CDSS (current depression) suicide item excluded 1.22 (1.10 – 1.35)*** 1.09 (1.00 – 1.18)*
aThe data in the columns presents the odds ratios for participants with SA + NSSH or SA only having the given characteristic compared to participants with NoSA
(reference category). Levels of statistical significance: ns = not significant * = p < 0.05, ** = p < 0.01, *** = p < 0.001.
bVariables entered in Model 1: Age of first psychotic symptoms, Depressive episode, First symptoms before the age of 18, DUP > 52 weeks, Gender.
cVariables entered in Model 2: step 1 + Current medication, GAF F, CDSS (current depression), PANSS G14 (Impulsive aggression), InterSePT 5 (Current suicidality).
Step 2 Model chi-square = 311.084, df = 10, p < .001. The model as a whole explained between 31% (Cox and Snell R2) and 37% (Nagelkerke R2) of the variance
and correctly identified 71% of the cases. n = 233 in the final model.
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[16,30,31]. SA + NSSH patients were younger than the
other patients in our sample. Since the current sample is
relatively young with short durations of treated illness,
cohort effects and recall bias are not likely to explain the
observed differences. We would thus argue that it is
likely that SA + NSSH are more prevalent among pa-
tients with earlier onset of schizophrenia, in line with
our original hypotheses.
We also found support for our hypothesis of more
current impulsive aggression and depressive symptoms
among patients with SA + NSSH, suggesting a link be-
tween NSSH or repeated self-harm behaviors and distur-
bances of affect regulation also in schizophrenia patients.
This is in line with a previous finding of an association
between affective variability and suicidal ideation in indi-
viduals with high risk for developing schizophrenia [32].
Depression/depressive symptoms, suicidal ideation, im-
pulsivity and repeated self-harm behaviors are symptoms
and behaviors found to be linked to each other and to
underlying problems with affect regulation in other diag-
nostic groups, especially borderline personality disorder
(BPD) [17]. Since we did not interview specifically for
personality disorders it is possible that patients with
SA + NSSH in the present sample displayed BPD traits in
addition to schizophrenia. Studies of prodromal or recent
onset schizophrenia patients show that they may experi-
ence a wide array of comorbid syndromes, including pre-
morbid BPD [33,34]. However, the lower age of onset for
psychotic symptoms in the SA + NSSH group might also
indicate that the emergence of psychotic symptoms dur-
ing adolescence can increase the risk of self-harm [35],perhaps to regulate affect. Severity of depressive symp-
toms and suicidal behavior are robust predictors of future
suicide attempts in adult samples of schizophrenia pa-
tients [4,36] and a recent study of children and ado-
lescents with first episode psychoses also found that
depressive symptoms and high suicidality at baseline was
associated with increased risk for suicide attempts in the
follow-up period [37]. That study did not report on NSSH,
but such findings highlights that the higher severity of de-
pressive symptoms and higher current suicidality in pa-
tients with both SA and NSSH increase the risk of future
suicide attempts.
Studies of first episode patients (including a subsample
of the current) indicate that longer DUP is associated
with suicidality [6,38,39]. The current study did not have
an a-priori hypothesis regarding the role of DUP, but
included the measure as part of a range of potential
risk indicators. It is of clinical importance that the SA +
NSSH group had significantly longer DUPs while at the
same time more than half of the group reported that they
had their first treatment contact with mental health
services early, but for other reasons than their psychotic
disorder. It is thus unlikely that the observed treat-
ment delay is explained by unfamiliarity with mental
health services. Rather we could speculate that early
onset of depression, possibly in combination with re-
peated self-harm behaviors and/or other symptoms and
behavior such as suicidal ideation and impulsive ag-
gression may have delayed a thorough diagnostic as-
sessment of their psychotic symptoms. From this point
of view it is important to note that one third of the SA +
NSSH patients currently did not use any antipsychotic
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http://www.biomedcentral.com/1471-244X/13/255medication; a significantly lower fraction than among
NoSA patients.
Strengths and limitations
Strengths: The strengths of the study include the relatively
large and representative sample recruited from publicly
funded catchment area based services serving all socio-
economic classes as well as the use of comprehensive clin-
ical assessments performed by qualified and trained clinical
interviewers. Limitations include the cross-sectional design
preventing inferences about causal relationships, the gen-
eral problems with recall bias for retrospective data, the
lack of data on the age of onset of SA + NSSH and the use
of PANSS item G14 as a proxy measure for impulsive ag-
gression. The relatively small size of the groups of interest
increases the risk of Type II error. Findings must thus be
interpreted with some caution.
Conclusions
The results of the current study indicate that non-
suicidal self-harm is highly prevalent in patients with
schizophrenia, and that the subgroup with both suicide
attempts and non-suicidal self-harm could constitute a
distinctive subpopulation characterized by an early onset
of psychotic symptoms and yet a significant delay of
treatment for psychosis. The high frequency of suicide at-
tempts combined with higher levels of impulsive aggres-
sion and depressive symptoms suggest that this group
may be at increased risk for severe suicidal behavior in the
future. Assessment of non-suicidal self-harm should be
part of standard suicide risk assessment of schizophrenia
patients. These results suggest that an early- and thorough
diagnostic assessment of psychotic symptoms in indi-
viduals with both suicide attempts and non-suicidal
self-harm is important to prevent delayed treatment and
perhaps increased risk of repeated non-suicidal self-harm
and severe suicide attempts.
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